Clinical trial
A Randomised, Double Blind, Placebo Controlled, Multi-centre, Parallel Group, Interventional Study of Mesalazine (Asacol�) Treatment in IBS and the Evaluation of Rectal Inflammatory Status using the Mucosal Patch Technique
To assess the effect of mesalazine (Asacol�) treatment compared to placebo on IBS symptoms.
| Category | Value |
|---|---|
| Study start date | 2011-12-05 |